WHO Advises Against Gilead’s Remdesivir For All Hospitalised Covid-19 Patients
Gilead’s drug Remdesivir is not recommended for patients hospitalized with Covid-19, regardless of how ill they are, as there is no evidence it improves survival or reduces the need for…
Share